| Convertible Preferred Stock | Additional | Total | ||||||||||||||||||||||||||||||||||
| Series Seed | Series A | Common Stock | Paid-in | Accumulated | Stockholders’ | |||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Capital | Deficit | Deficit | ||||||||||||||||||||||||||||
| Balance at December 31, 2022 (Predecessor) | 5,155,703 | $ | 4,077,560 | 22,764,764 | $ | 38,023,784 | 9,044,733 | $ | 904 | $ | 928,560 | $ | (35,800,244) | $ | (34,870,780) | |||||||||||||||||||||
| Issuance of common stock from exercise of stock options | - | - | - | - | 16,666 | 2 | 5,165 | - | 5,167 | |||||||||||||||||||||||||||
| Stock based compensation expense | - | - | - | - | - | - | 28,144 | - | 28,144 | |||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | (2,438,330) | (2,438,330) | |||||||||||||||||||||||||||
| Balance at March 31, 2023 (Predecessor) | 5,155,703 | $ | 4,077,560 | 22,764,764 | $ | 38,023,784 | 9,061,399 | $ | 906 | $ | 961,869 | $ | (38,238,574) | $ | (37,275,799) | |||||||||||||||||||||
| Issuance of common stock from exercise of stock options | - | - | - | - | 7,500 | 1 | 599 | - | 600 | |||||||||||||||||||||||||||
| Stock based compensation expense | - | - | - | - | - | - | 27,277 | - | 27,277 | |||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | (2,236,718) | (2,236,718) | |||||||||||||||||||||||||||
| Balance at June 30, 2023 (Predecessor) | 5,155,703 | $ | 4,077,560 | 22,764,764 | $ | 38,023,784 | 9,068,899 | $ | 907 | $ | 989,745 | $ | (40,475,292) | $ | (39,484,640) | |||||||||||||||||||||
| Stock based compensation expense | - | - | - | - | - | - | 23,498 | - | 23,498 | |||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | (1,349,347) | (1,349,347) | |||||||||||||||||||||||||||
| Balance at September 30, 2023 (Predecessor) | 5,155,703 | $ | 4,077,560 | 22,764,764 | $ | 38,023,784 | 9,068,899 | $ | 907 | $ | 1,013,243 | $ | (41,824,639) | $ | (40,810,489) | |||||||||||||||||||||
| For the three months ended September 30, | For the period from February 14, 2024 through September 30, | For the period from January 1, 2024 through February 13, | For the nine months ended September 30, | |||||||||||||||||
| 2024 | 2023 | 2024 | 2024 | 2023 | ||||||||||||||||
| (Successor) | (Successor) | (Successor) | (Predecessor) | (Predecessor) | ||||||||||||||||
| Operating leases: | ||||||||||||||||||||
| Operating lease cost | $ | 229,331 | $ | 233,375 | $ | 585,702 | $ | 110,885 | $ | 695,365 | ||||||||||
| Variable operating lease cost | 177,056 | 147,942 | 441,560 | 84,401 | 488,867 | |||||||||||||||
| Total lease cost | $ | 406,387 | $ | 381,317 | $ | 1,027,262 | $ | 195,286 | $ | 1,184,232 | ||||||||||
| Convertible Preferred Stock | Series A | Additional | Stock | |||||||||||||||||||||||||||||||||||||||||||||
| Series A | Series B | Series C | Common Stock | Paid-in | Subscriptions | Accumulated | ||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Capital | Receivable | Deficit | Total | |||||||||||||||||||||||||||||||||||||
| Balance at February 14, 2024 (Successor) | 10,039 | $ | 8,937,852 | - | $ | - | - | $ | - | 14,531,847 | $ | 1,452 | $ | 53,898,434 | $ | (2,000,000) | $ | (63,185,641) | $ | (2,347,903) | ||||||||||||||||||||||||||||
| Issuance of Series B shares sold to investors | - | - | 626 | 500,000 | - | - | - | - | - | (500,000) | - | - | ||||||||||||||||||||||||||||||||||||
| Stock-based compensation | - | - | - | - | - | - | - | - | 96,289 | - | - | 96,289 | ||||||||||||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | - | - | - | (1,727,483) | (1,727,483) | ||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2024 (Successor) | 10,039 | $ | 8,937,852 | 626 | $ | 500,000 | - | - | 14,531,847 | $ | 1,452 | $ | 53,994,723 | $ | (2,500,000) | $ | (64,913,124) | $ | (3,979,097) | |||||||||||||||||||||||||||||
| Cash received for Series B stock subscription | - | - | - | - | - | - | - | - | - | 500,000 | - | 500,000 | ||||||||||||||||||||||||||||||||||||
| Issuance of Series A shares for rounding purchases | 3 | 1,875 | - | - | - | - | - | - | 128 | - | - | 2,003 | ||||||||||||||||||||||||||||||||||||
| Issuance of common stock for Arena Equity Line of Credit (ELOC) | - | - | - | - | - | - | 345,566 | 35 | 499,965 | - | - | 500,000 | ||||||||||||||||||||||||||||||||||||
| Purchases of Common Stock under Keystone ELOC, net of issuance costs of $933,345 | - | - | - | - | - | - | 7,860,351 | 786 | 1,699,327 | (194,971) | - | 1,505,142 | ||||||||||||||||||||||||||||||||||||
| Stock-based compensation | - | - | - | - | - | - | - | - | 1,388,738 | - | - | 1,388,738 | ||||||||||||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | - | - | - | (2,448,654) | (2,448,654) | ||||||||||||||||||||||||||||||||||||
| Balance at June 30, 2024 (Successor) | 10,042 | $ | 8,939,727 | 626 | $ | 500,000 | - | - | 22,737,764 | $ | 2,273 | $ | 57,582,881 | $ | (2,194,971) | $ | (67,361,778) | $ | (2,531,868) | |||||||||||||||||||||||||||||
| Issuance of shares of Series A Preferred Stock on exercise of Series A Preferred Warrants | 38 | 38,000 | - | - | - | - | - | - | (38,000) | 38,000 | - | 38,000 | ||||||||||||||||||||||||||||||||||||
| Issuance of common stock for Keystone ELOC | - | - | - | - | - | - | 1,613,944 | 161 | (161) | - | - | - | ||||||||||||||||||||||||||||||||||||
| Purchases of shares of Common Stock under Keystone ELOC | - | - | - | - | - | - | 12,997,921 | 1,300 | 1,704,431 | 194,971 | - | 1,900,702 | ||||||||||||||||||||||||||||||||||||
| Issuance of shares of Common Stock on conversion of Series A Preferred Stock | (7,005) | (7,005,000) | - | - | - | - | 108,948,903 | 10,895 | 6,994,105 | - | - | - | ||||||||||||||||||||||||||||||||||||
| Issuance of shares of Common Stock on conversion of Series B Preferred Stock | - | - | (140) | (140,000) | - | - | 1,244,040 | 124 | 139,876 | - | - | - | ||||||||||||||||||||||||||||||||||||
| Issuance of shares of Series C Preferred Stock sold to investors, net of issuance costs of $434,428 | - | - | - | - | 2,853 | 1,249,999 | - | - | (434,428) | (111,607) | - | 703,964 | ||||||||||||||||||||||||||||||||||||
| Stock-based compensation | - | - | - | - | - | - | - | - | 414,744 | - | - | 414,744 | ||||||||||||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | - | - | - | (4,227,967) | (4,227,967) | ||||||||||||||||||||||||||||||||||||
| Balance at September 30, 2024 (Successor) | 3,075 | $ | 1,972,727 | 486 | $ | 360,000 | 2,853 | $ | 1,249,999 | 147,542,572 | $ | 14,753 | $ | 66,363,448 | $ | (2,073,607) | $ | (71,589,745) | $ | (3,702,425) | ||||||||||||||||||||||||||||
| For the nine months ended September 30, | ||||||||||||
| 2024 | ||||||||||||
| (Pro forma, Predecessor and Successor) | 2023 (Predecessor) | Difference | ||||||||||
| Net cash used in operating activities | $ | (11,375,873) | $ | (4,829,217) | $ | (6,546,656) | ||||||
| Net cash provided by financing activities: | 12,240,682 | 571,679 | 11,669,003 | |||||||||
| Net increase (decrease) in cash and cash equivalents | $ | 864,809 | $ | (4,257,539) | $ | 5,122,347 | ||||||
| For the three months ended September 30, | For the period from February 14, 2024 through September 30, | For the period from January 1, 2024 through February 13, | For the nine months ended September 30, | |||||||||||||||||
| 2024 | 2023 | 2024 | 2024 | 2023 | ||||||||||||||||
| (Successor) | (Predecessor) | (Successor) | (Predecessor) | (Predecessor) | ||||||||||||||||
| Operating expenses: | ||||||||||||||||||||
| Research and development | $ | 1,774,210 | $ | 1,277,558 | $ | 5,392,569 | $ | 764,192 | $ | 4,270,472 | ||||||||||
| General and administrative | 2,628,028 | 258,013 | 7,812,843 | 132,941 | 2,283,404 | |||||||||||||||
| Total operating expenses | 4,402,238 | 1,535,571 | 13,205,412 | 897,133 | 6,553,876 | |||||||||||||||
| Loss from operations | (4,402,238) | (1,535,571) | (13,205,412) | (897,133) | (6,553,876) | |||||||||||||||
| Other income | - | - | 589,223 | - | - | |||||||||||||||
| Other expense | (147) | - | (630,922) | - | - | |||||||||||||||
| Change in fair value of derivative liabilities | 170,000 | 186,067 | 4,870,000 | 320,117 | 411,230 | |||||||||||||||
| Interest income, net | 4,418 | 157 | (26,993) | 4,805 | 118,251 | |||||||||||||||
| Total other income | 174,271 | 186,224 | 4,801,308 | 324,922 | 529,481 | |||||||||||||||
| Net loss | $ | (4,227,967) | $ | (1,349,347) | $ | (8,404,104) | $ | (572,211) | $ | (6,024,395) | ||||||||||
| Net loss per share: | ||||||||||||||||||||
| Basic and diluted | $ | (0.09) | $ | (0.15) | $ | (0.28) | $ | (0.06) | $ | (0.67) | ||||||||||
| Weighted average common shares outstanding: | ||||||||||||||||||||
| Basic and diluted | 49,675,773 | 9,068,899 | 30,000,286 | 9,068,899 | 9,058,608 | |||||||||||||||
